Clinical Trial Update: Bioequivalence Study of BGM0504 Injection [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of BGM0504 Injection is currently recruiting for overweight/obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM0504 Injection (BGM0504)

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Overweight/Obesity | Phase 1 | Status: RECRUITING